Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.088 | 0.009 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.01 |
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |